George Farmer
Stock Analyst at Scotiabank
(2.50)
# 2,250
Out of 5,179 analysts
70
Total ratings
47.37%
Success rate
1.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.32 | +657.58% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $114.57 | +16.09% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.12 | -46.43% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $17.17 | +173.73% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $23.49 | -27.63% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $4.94 | +142.91% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $1.73 | +420.23% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $13.18 | +211.08% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $29.98 | +73.45% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $54.14 | +47.77% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $183.84 | +21.85% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $32.52 | +213.65% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $7.74 | +29.20% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $691.40 | +3.41% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $6.27 | +266.83% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.58 | +3,366.20% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $16.80 | +352.38% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.78 | +367.63% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $49.56 | +119.94% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $90.30 | -3.65% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.41 | +1,269.29% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.09 | +3,569.72% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $41.53 | -34.99% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.32
Upside: +657.58%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $114.57
Upside: +16.09%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.12
Upside: -46.43%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $17.17
Upside: +173.73%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $23.49
Upside: -27.63%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $4.94
Upside: +142.91%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $1.73
Upside: +420.23%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $13.18
Upside: +211.08%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $29.98
Upside: +73.45%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $54.14
Upside: +47.77%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $183.84
Upside: +21.85%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $32.52
Upside: +213.65%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $7.74
Upside: +29.20%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $691.40
Upside: +3.41%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $6.27
Upside: +266.83%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.58
Upside: +3,366.20%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $16.80
Upside: +352.38%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.78
Upside: +367.63%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $49.56
Upside: +119.94%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $90.30
Upside: -3.65%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.41
Upside: +1,269.29%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.09
Upside: +3,569.72%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $41.53
Upside: -34.99%